APA (7th ed.) Citation

Hegedűs, Z. I., Jakab, M. E., Gergely, T. G., Sayour, N. V., Kovács, A., Antal, S., . . . Tóth, V. E. (2025). Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: Comparison to liraglutide. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02806-5

Chicago Style (17th ed.) Citation

Hegedűs, Zsombor I., et al. "Tirzepatide, a Dual GIP/GLP1-receptor Co-agonist Preserves Cardiac Function and Improves Survival in Angiotensin II-induced Heart Failure Model in Mice: Comparison to Liraglutide." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02806-5.

MLA (9th ed.) Citation

Hegedűs, Zsombor I., et al. "Tirzepatide, a Dual GIP/GLP1-receptor Co-agonist Preserves Cardiac Function and Improves Survival in Angiotensin II-induced Heart Failure Model in Mice: Comparison to Liraglutide." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02806-5.